for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Clearpoint Neuro Inc

CLPT.OQ

Latest Trade

17.50USD

Change

1.74(+11.04%)

Volume

117,606

Today's Range

15.41

 - 

17.99

52 Week Range

2.88

 - 

17.99

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
15.76
Open
16.69
Volume
117,606
3M AVG Volume
4.07
Today's High
17.99
Today's Low
15.41
52 Week High
17.99
52 Week Low
2.88
Shares Out (MIL)
16.87
Market Cap (MIL)
260.80
Forward P/E
-37.67
Dividend (Yield %)
--

Next Event

Q4 2020 Clearpoint Neuro Inc Earnings Release

Latest Developments

More

Clearpoint Neuro Reports Record Revenue In Preliminary Q4 2020 Results

Clearpoint Neuro Reports Third Quarter 2020 Results

Clearpoint Neuro Says Danilo D'Alessandro Appointed Chief Financial Officer

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Clearpoint Neuro Inc

Clearpoint Neuro Inc, formerly MRI Interventions, Inc., MRI Interventions, Inc. is a medical device company. The Company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It has two product platforms: ClearPoint system, which is used to perform minimally invasive surgical procedures in the brain and ClearTrace system, which is under development, to be used to perform minimally invasive surgical procedures in the heart. Its ClearPoint system is a neuro-navigation system designed for placing catheters and electrodes to treat a range of neurological diseases and conditions and for performing biopsies. Its ClearTrace system is designed to deliver catheter-based therapies to treat certain cardiac diseases. Both systems utilize intra-procedural MRI to guide the procedures.

Industry

Medical Equipment & Supplies

Contact Info

5 Musick

IRVINE, CA

92618-1638

United States

+1.949.9006833

https://www.clearpointneuro.com/

Executive Leadership

Kimble L. Jenkins

Chairman of the Board

Joseph Michael Burnett

President, Chief Executive Officer, Director

Danilo D Alessandro

Chief Financial Officer

Peter G. Piferi

Chief Operating Officer

R. John Fletcher

Lead Independent Director

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2020(E)

0.0K
EPS (USD)

2020(E)

-0.480
Price To Earnings (TTM)
--
Price To Sales (TTM)
21.16
Price To Book (MRQ)
1,646.72
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
11,901.01
LT Debt To Equity (MRQ)
11,851.38
Return on Investment (TTM)
-50.26
Return on Equity (TTM)
-38.86

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up